A novel therapeutic anti-ErbB3, ISU104 exhibits potent antitumorigenic activity by inhibiting ligand binding and ErbB3 heterodimerization

Mirim Hong, Youngki Yoo, Miyoung Kim, Ju Yeon Kim, Jeong Seok Cha, Myung Kyung Choi, Uijin Kim, Kyungyong Kim, Youngsoo Sohn, Donggoo Bae, Hyun Soo Cho, Seung Beom Hong

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A novel therapeutic anti-ErbB3, ISU104 exhibits potent antitumorigenic activity by inhibiting ligand binding and ErbB3 heterodimerization'. Together they form a unique fingerprint.

Medicine & Life Sciences